Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Thymoma × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 7 Recurrence 5 Glioblastoma 4 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Neoplasms, Plasma Cell 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thymoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Richter's Transformation 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1

Interventions

Taxes 2 Sunitinib 2 Paclitaxel 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Carboplatin 2 selinexor 1 saracatinib 1 pembrolizumab 1 epacadostat 1 belinostat 1 amrubicin 1 Thymectomy 1 Robotic Surgical Procedures 1 Ramucirumab 1 Prednisone 1 Prednisolone 1 Pemetrexed 1 MK 2206 1 Lapatinib 1 Fentanyl 1 Erlotinib Hydrochloride 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03193437 2023-02-16

SELECT

Georgetown University

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡